The IMARC Group's latest research report, titled “Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide), Application (Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders), and Region 2025-2033,” offers a comprehensive analysis of the oral proteins and peptides market share. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

How Big is the Oral Proteins and Peptides Market?

The global oral proteins and peptides market size was valued at USD 1.8 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 3.4 Billion by 2033, exhibiting a CAGR of 7.13% from 2025-2033.

Request Free Sample Report– https://www.imarcgroup.com/oral-proteins-peptides-market/requestsample

Oral Proteins and Peptides Market Dynamics:

Rise of Chronic Diseases & Aging Population:

Chronic illnesses like diabetes, cardiovascular diseases and autoimmune disorders are on the rise, And, one area that has been impacted by their propagation is the oral proteins and the peptides market. Why? Because, more often than not, these chronic diseases require one to take long term therapy, and if one takes oral approaches as opposed to injectables, it is more Pet friendly and convenient. Furthermore, The older generation tend to be more prone to chronic diseases, and there is always a large such population.

Technological Advancements in Drug Delivery:

Innovative drug delivery methods offer potential solutions to the problems associated with the oral intake of proteins and peptides, and significant progress has been made in that area. For instance, various approaches, such as developing new formulations like nanoparticles and microparticles, improve the stability, bioavailability and absorption of these molecules in the gastrointestinal tract. In addition, the technical achievements in polymer chemistry and bioengineering are making it possible to design more efficient and selective systems for drug delivery.

Growing Emphasis on Personalized Medicine:

The growing focus on precision medicine encourages the invention of protein and peptide oral therapies that are more suitable for a specific person. For example, by having detailed information on a patient, including their genetics and the expected evolution of diseases, the system can be more focused and effective. Such an approach will likely optimize the effectiveness of treatment, improve the safety of treatment and increase the patient’s comfort.

Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/oral-proteins-peptides-market

Oral Proteins and Peptides Market Trends:

Several general market trends have been outlined in the oral proteins and peptides market. The first is the market is driven by the need to develop new therapies for existing clients with unfulfilled medical needs with a focus on oncology, neurology and metabolic disorders. The second trend is the increase in the development of biosimilars and biobetters of oral protein and peptide therapies, aiming to provide more affordable and accessible treatment options. The marketplace has never been so lucrative with the increase in research and development focusing on improving drug delivery, enhancing therapeutic efficacy, and minimizing the side effects. Combination therapies that incorporate oral proteins and peptides with small molecules and biologics are gaining traction and are expected to be integrated into medicine in the future.

Oral Proteins and Peptides Market Report Segmentation:

Breakup By Drug Type:

• Linaclotide
• Plecanatide
• Calcitonin
• Insulin
• Octreotide

Insulin holds the leading market position due to its widespread usage in managing diabetes and its significant therapeutic role in blood glucose control.

Breakup By Application:

• Gastric and Digestive Disorders
• Bone Diseases
• Diabetes
• Hormonal Disorders

Diabetes holds the leading market position as oral proteins, and peptides are primarily developed to improve diabetic management, catering to the large patient population. 

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

North America holds the leading market position due to its advanced healthcare infrastructure and significant investments in biopharmaceuticals. The region's supportive regulatory environment accelerates the approval and adoption of innovative treatments.

Top Oral Proteins and Peptides Market Leaders:

The oral proteins and peptides market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Amryt Pharma Plc
• AstraZeneca PLC
• Biocon Limited
• Novo Nordisk A/S
• Oramed Ltd
• Proxima Concepts Limited

Note: Should you require specific information not included in the current report, we are pleased to offer customization options to meet your needs.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145